CARPENTER CHRISTOPHER L.

Track

Insider profile

CARPENTER CHRISTOPHER L.'s trades of Rubius Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-09-18 2019-09-17
PlS Planned sale
41,058 +25.0%
226.13
US$3,116,864 		41,058 +25.0% 226.13 US$3,116,864
2019-09-18 2019-09-16
PlS Planned sale
19,228 +31.6%
368.68
US$1,587,997 		19,228 +31.6% 368.68 US$1,587,997
2019-06-24 2019-06-20
PlS Planned sale
16,513 -14.4%
84.36
US$2,047,736 		16,513 -14.4% 84.36 US$2,047,736
2019-06-19 2019-06-19
PlS Planned sale
18,399 -34.6%
13.80
US$253,868 		18,399 -34.6% 13.80 US$253,868
2019-06-19 2019-06-18
PlS Planned sale
10,858 -23.8%
14.27
US$154,958 		10,858 -23.8% 14.27 US$154,958
2019-06-19 2019-06-17
PlS Planned sale
18,500 -34.7%
14.10
US$260,868 		18,500 -34.7% 14.10 US$260,868
2019-03-19 2019-03-15
PlS Planned sale
48,000 -57.9%
15.84
US$760,114 		48,000 -57.9% 15.84 US$760,114